This announcement is a separate document:
关于浙江圣达生物药业股份有限公司向特定对象发行股票申请文件的第二轮审核问询函的回复（修订稿）（2024年半年度财务数据更新版）
Response to the second round review inquiry letter of Zhejiang Shengda Biopharmaceutical Co., Ltd. to issue stock applications to specific targets (revised draft) (2024 semi-annual financial data update)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.